April 5 (Reuters) - Aradigm Corp:
* ARADIGM ANNOUNCES THE EMA HAS COMPLETED ITS VALIDATION OF THE MAA SUBMISSION
* OPINION OF COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) FOR LINHALIQ EXPECTED WITHIN 210 DAYS Source text for Eikon: Further company coverage: